Arkolith/Insider Trading/BHVN/Form 4

Gentile Kimberly

SVP, Clinical OperationsBiohaven Ltd. (BHVN) · full profile →Form 4 · filed Jan 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2025Tax withholding(F)2K$38.64$76K98K
Jan 5, 2025Option exercise(M)4K—$0100K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 5, 2025Option exercise(M)4K—$011K
Jan 5, 2025Grant(A)91K—$091K
Jan 5, 2025Grant(A)15K—$015K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001935979-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML